Ethnobotany and ethnopharmacology of Tabernaemontana divaricata

Indian Journal of Medical Research

Volumn 127, Issue 4, 2008, Pages 317-335

  Pratchayasakul, Wasana ^a   Pongchaidecha, Anchalee ^a   Chattipakorn, Nipon ^a   Chattipakorn, Siriporn ^a,b  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Alkaloids; Non alkaloids; Pharmacological properties; Tabernaemontana divaricata

Indexed keywords

11 METHOXY N METHYLDIHYDROPERICYCLIVINE; 12 HYDROXYAKUAMMICINE; 19 EPIVOACANGINE; 19 EPIVOACRISTINE; 19 HEYNEANINE HYDROXYINDOENINE; 19 HYDROXYCORONARIDINE; ALKALOID DERIVATIVE; APPARICIN; CONOPHYLLINE; CORONARIDINE; DREGAMINE; IBOGAMINE; ISOVOACANGINE; ISOVOACRISTINE; LAHORICINE; PERICYCLIVINE; PERIVINE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; TABERNAEMONTANA DIVARICATA EXTRACT; TABERNAEMONTANINE; UNINDEXED DRUG; VOBASINE;

ALZHEIMER DISEASE; ANALGESIA; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ASCITES; ASTHENIA; CENTRAL NERVOUS SYSTEM; CHEMOTAXONOMY; CHOLINERGIC ACTIVITY; DEGENERATIVE DISEASE; DRUG POTENCY; DRUG STRUCTURE; ETHNOBOTANY; ETHNOPHARMACOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; LYMPHOMA; MYASTHENIA GRAVIS; NONHUMAN; PAW EDEMA; PERIPHERAL NERVOUS SYSTEM; PHYTOCHEMISTRY; RESPIRATION DEPRESSION; REVIEW; TABERNAEMONTANA; TABERNAEMONTANA DIVARICATA; TOXICITY TESTING; TRADITIONAL MEDICINE;

ETHNOBOTANY; ETHNOPHARMACOLOGY; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; TABERNAEMONTANA;

EID: 51349097371     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Boonyaratanakornkit L, Supawita T. Names of medicinal plants and their uses. Bangkok: Department of Pharmacognosy, Faculty of Pharmacy, Chulalongkorn University, 2005. p.69.
2. van Beek TA, Verpoorte R, Svendsen AB, Leeuwenberg AJ, Bisset NG. Tabernaemontana L. (Apocynaceae): a review of its taxonomy, phytochemistry, ethnobotany and pharmacology. J Ethnopharmacol 1984; 10: 1-156.
3. Leeuwenberg AJM. A revision of Tabernaemontana. The old world species. Part I, Royal Botanic Gardens, kew:whitstabee litho Ltd., Whitstable, UK; 1991.
4. Phu-pattanaphong L. Thai medicinal plants, Part 2. Bangkok: New Thammada Publishing; 1979. p. 113-6.
5. Smitinan T. Thai plant names (botanical names-vernacular names). Bangkok, Thailand: Royal Forest Department, 1980, p.141.
6. Pitard J. Apocynaceae. Paris: Flore Generale de l'Indochine, 1933.
7. Kerr AFG. Apocynaceae. Bangkok: Florae Siamensis Enumeratio; 1939.
8. Arambewela LSR, Ranatunge T. Indole alkaloid from Tabernaemontana divaricata. Phytochemistry 1991; 30: 1740-1.
9. Atta-ur-Rahman, Muzaffar A, Doulatabadi N. The isolation and structure of Mehranine-A new indole alkaloid from Ervatamia coronaria. Natuforsch 1983; 38 (12 Ptb): 1700.
10. Atta-ur-Rahman, Muzaffar A. The isolation and structure of ervaticine-A new alkaloid from Ervatamia coronaria. Heterocycles 1985; 23: 2975-8.
11. Atta-ur-Rahman, Muzafflar A, Daulatabadi A. Isolation and structure of stapfinine-A new indole alkaloid from Ervatamia coronaria. Phytochemistry 1986; 25: 1781.
12. Atta-ur-Rahman, Muzaffar A, Daulatabadi A. Ervatinine, an indole alkaloid from Ervalamia coronaria. Phytochemistry 1985; 24: 2473-4.
13. Dagnino D, Schripsema J, Verpoorte R. Comparison of terpenoid indole alkaloid production and degradation in two cell lines of Tabernaemontana divaricata. Plant Cell Rep 1993; 13: 95-8.
14. Dagnino D, Schripsema J, Verpoorte R. Alkaloid metabolism in Tabernaemontana divaricata cell suspension cultures. Phytochemistry 1993; 32: 325-9.
15. Dagnino D, Schripsema J, Verpoorte R. Terpenoid indole alkaloid biotransformation capacity of suspension cultures of Tabernaemontana divaricata. Phytochemistry 1994; 35 671-6.
16. Henriques AT, Melo AA, Moreno PR, Ene LL, Henriques,IA, Schapoval EE. Ervatamia coronaria: chemical constituents and some pharmacological activities. J Ethnopharmacol 1996; 50: 19-25.
17. Ingkaninan K, Uzerman AP, Taesotikul T, Verpoorte R. Isolation of opioid active compounds from Tabernaemontana pachysiphon leaves. J Pharm Pharmacol 1999; 51: 1441-6.
18. Kam TS, Loh KY, Lim LH, Loong WL, Chuah CH, Wei C. New alkaloids from the leaves of Tabernaemontana divaricata. Tetrahedron Lett 1992; 33: 969-72.
19. Kam TS, Loh KY, Wei C. Conophylline and conophyllidine: new dimeric alkaloids from Tabernaemontana divaricata. J Nat Prod 1993; 56: 1865-71.
20. Kam TS, Anuradha S. Alkaloids from Tabernaemontana divaricata. Phytochemistry 1995; 40: 313-6.
21. Kam TS, Anuradha S. Voafinine and N1-methylvoafinine, novel aspidosperma alkaloids from Tabernaemontana. Nat Prod Lett 1995; 7: 191-5.
22. Kam TS, Anuradha S, Loh KY. Voafinidine and voalenine, a novel indoles of the aspidosperma alkaloids from Tabernaemontana. Natural Product Letters 1996; 8: 49-53.
23. Kam TS, Pang HS, Lim TM. Biologically active indole and bisindole alkaloids from Tabernaemontana divaricata. Org Biomol Chem 2003; 1: 1292-7.
24. Kam TS, Choo YM, Komiyama K. Biologically active ibogan and vallesamine derivatives from Tabernaemontana divaricata. Chem Biodivers 2004; 1: 646-56.
25. Kam TS, Sim KM. Conodurine, conoduramine, and ervahanine derivatives from Tabernaemontana corymbosa. Phytochemistry 2003; 63: 625-9.
26. Karawya MS, Aboutabl EA. Phytochemical studies of Abrus precatorius alkaloids. J Pharm Sci 1979; 20: 241.
27. Pawelka KH, Stoeckigt J. Indole alkaloids from cell suspension cultures of Tabernaemontana divaricata and Tabernaemontana iboga. Plant Cell Rep 1983; 22: 105-7.
28. Raj K, Shoeb A, Kapil RS, Popli SP. Alkaloids of Tabernaemontana divaricata. Phytochemistry 1974; 13: 1621-2.
29. Rastogi K, Kapil RS, Popli SP. New alkaloids from Tabernaemontana divaricata. Phytochemistry 1980; 19: 1209-12.
30. Schneider JA, Sigg EB. Neuropharmacological studies on ibogaine, an indole alkaloid with central stimulant properties. Ann N Y Acad Sci 1957; 66: 765-6.
31. Schripsema J, Peltenburg-Looman A, Erkelens C, Verpoorte R. Nitrogen metabolism in Cultures of Tabernaemontana divaricata. Phytochemistry 1991; 30: 3951-4.
32. Sierra M, Van der Heijden R, van der Leer T, Verpoorte R. Stability of alkaloid production in cell suspension cultures of Tabernaemontana divaricata during long-term sunculture. Plant Cell Tiss Org Cult 1992; 28: 59-68.
33. Stevens LH, Blom TIM, Verpoorte R. Subcellular localization of Tabernaemontana roseus and Tabernaemontana divaricata. Plant Cell Rep 1993; 12: 573-6.
34. van Beek TA, Verpoorte R, Kinh PQ. Pseudovobparicine, a new dimeric indole alkaloid from Tabernaemontana divaricata. Planta Medica 1985; 3: 227-79.
35. van der Heijden R, Hermans-Lokkerbol A, De Kool LP, Lamping PJ, Harkes PAA, Verpoorte R. Pharmacognostical studies of Tabernaemontana species. Part 19. Accumulation of indole alkaloids in suspension culyure of Tabernaemontana divaricata. Planta Med 1988; 54: 393-7.
36. van der Heijden R, Van der Graff GM, Pennings Ed.JM, Verpoorte R. Formation and degradation of some aspidospermatan indole alkaloids in a suspension culture of Tabernaemontana divaricata. Plant Physiol Biochem 1990; 28: 351-8.
37. Sharma P, Cordell GA. Heyneanine hydroxyindolenine, a new indole alkaloid from Ervatamia coronaria var. plena. J Nat Prod 1988; 51: 528-31.
38. van Der Heijden R. Indole alkaloids in cell and tissue cultures of Tabernaemontana species. Pharm Weekbl Sci 1989; 11 239-41.
39. van der Heijden R, Lamping PJ, Out PP, Wijnsma R, Verpoorte R. High-performance liquid chromatographic determination of indole alkaloids in a suspension culture of Tabernaemontana divaricata. J Chromatogr 1987; 396 287-95.
40. van der Heijden R, Threlfall DR, Verpoorte R, Whitehead IM. Studies on the regulation and enzymology of pentacyclic triterpenoid phytoalexin biosynthesis in cell suspension cultures of Tabernaemontana divaricata. Phytochemistry 1989; 28: 2981-8.
41. Dagino D, Schripsema J,Peltenburg A Verpoorte R. Capillary gas chromatographic analysis of indole alkaloids: investigation of the indole alkaloids present in Tabernaemontana divaricata cell suspension culture. J Nat Prod 1991; 54: 1558-63.
42. Daniel M, Sabnis SD. Chemotaxonomical studies in Apocynaceae. J Exp Biol 1978; 16: 512-3.
43. Sierra MI. Biochemical, molecular and physiological aspects of plant peroxidoses. Geneva: Imprimerie National; 1991.
44. Stevens LH, Schripsema J, Permings EJM, Verpoorte R. Activities of enzymes involved in indole alkaloid biosynthesis in suspension cultures of Catharanthus, Cinchoma and Tabernaemontana species. Plant Physiol Biochem 1992; 30: 675-81.
45. Cordell GA. The biosynthesis of indole alkaloids. Lloydia 1974; 37: 219-298.
46. Kutney JP, Hibino T, Jahngen E, Okutani T, Ratcliffe AH, Treasurywala AM, et al. Total synthesis of indole and dihydroindole alkaloids. IX. Studies on the synthesis of bisindole alkaloids in the vinblastine-vincristine series. Helv Chim Acta 1976; 59: 2858-82.
47. Ingkaninan K, Changwijit K, Suwanborirux K. Vobasinyliboga bisindole alkaloids, potent acetylcholinesterase inhibitors from Tabernaemontana divaricata root. J Pharm Pharmacol 2006; 58: 847-52.
48. Kam TS, Pang HS. Conodusarine, a new biologically active bisindole alkaloid from Tabernoemontana divaricata. Heterocycles 2004; 63: 845-50.
49. Atta-ur-Rahman, Daulatabadi A, Muzaffar A. The isolation and structure of lahoricine, a new indolenine alkaloid from Ervatamia coronoria. Z Naturforsch 1984; 39: 1289-91.
50. Poulsen C, Pennings EJM, Verpoone R. High-performance liquid chromatographic assay of anthranilate synthase from plant cell cultures. J Chromatogr 1991; 547: 155-60.
51. Fulton DC, Kroon PA, Threlfall DR. Enzymological aspects of the redirection of terpenoid biosynthesis in elicitor- treated cultures of Tabernaemontana divaricata. Phytochemistry 1994; 35: 1183-6.
52. Dagino D, Schripsema J, Verpoorte R. Terpenoid indole alkaloid biosynthesis and enzyme activities in two cell lines of Tabernaemontana divaricata. Phytochemistry 1995; 39: 341-9.
53. Luijendijk TJC, Nowak A, Verpoorte R. Strictosidine glucosidase from suspension cultured cells of Tabernaemontana divaricata. Phytochemistry 1996; 41: 1451-6.
54. Kroon PA, Threlfall DR. Squalene synthase from cell suspension cultures of Tabernaemontana divaricata. Phytochemistry 1997; 45: 1157-63.
55. Ramas-Valdivia AC, van der Heijden R, Verpoorte R. Isopentenyl diphosphate isomerase and prenyltransferase activities in rubiaceous and apocynaceous cultures. Phytochemistry 1998; 48: 961-9.
56. Rhodes MJC. Physiological roles for secondary metabolites in plants: some progress, many outstanding problems. Plant Mol Biol 1994; 24: 1-20.
57. Bennet JW, Bentley R. What's in a name? Microbial secondary metabolism. Adv Appl Microbiol 1989; 34: 1-28.
58. Luckner M, Nover M. Expression of secondary metabolism. An aspect of cell specialization of microorganisms, higher plants and animal. In: Luckner M, Nover L, Bohm H, editors. Secondary metabolism and cell differentiation. Heidelberg, Berlin: Springer Verlag; 1977. p. 3-82.
59. Constabel F. Cell culture in phytochemistry. In: Constabel F, Vasil IK, editors. Cell culture and somatic cell genetics of plants. London: Academic Press Inc; 1987. p. 3-13.
60. Lucumi E, Luczkiewicz M, Vera A, Hallard D, van der Heijden R, Verpoorte R. Alkaloid formation in cell suspension cultures of Tabernaemontana divaricata after feeding of tryptamine and loganin. Biotechnol Lett 2001; 23: 1691-6.
61. Schripsema J, Dagnino D, Santos RD, Verpoorte R. Breakdown of indole alkaloids in suspension cultures of Tabernaemontana divaricata and Catharanthus roseus. Plant Cell, Tisue Organ Cult 1994; 38: 299-305.
62. Mandal M, Mukherji S. A study on the activities of a few free radicals scavenging enzymes present in five roadside plants. J Environ Biol 2001; 22: 301-5.
63. Sharma DK, Prasad R. Biocrude and solid fuel from laticiferous plants. Biomass 1986; 11: 75-9.
64. Behera BK, Neerja M, Mukta A, Sharma DK. Production of petroleum hydrocarbons, fermentable sugars and ethanol from Tabernaemontana divaricata: A new fuel crop and renewable resource of energy. Energy Convers Manage 1995; 36: 281-8.
65. Flores-Sanchez IJ, Ortega-Lopez J, Carmen Montes-Horcasitas M, Ramos-Valdivia AC. Biosynthesis of sterols and triterpenes in cell suspension cultures of Uncaria tomentosa. Plant Cell Physiol 2002; 43: 1502-9.
66. Chaves CG, Schapoval EES, Zuanazzi JA, Diehl E, Siqueira NCS, Henriques AT. Erythroxylum argenium: assays for anti-inflammatory activity. J Ethopharmacol 1985; 27: 117-20.
67. Schapoval EES, Silveira SM, Miranda ME, Alice CB, Henriques AT. Evaluation of some pharmacological activities of Eugenia uniflora L. J Ethopharmacol 1994; 44: 137-42.
68. van Arman CG, Begany AT, Miller LM, Pless HH. Some details of the inflammations caused by yeast and carrageenin. J Pharmacol Exp Ther 1965; 150: 328-34.
69. Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med 1962; 111: 544-7.
70. Smith AC, Feehally J. New insights into the Pathogenesis of Ig A nephropatby Pathogenesis of Ig A nephopathy. Springer Semin Immunopathol 2003; 24: 477-93.
71. Lovett DH, Ryan JL, Sterzel RB. Stimulation of rat mesangial cell proliferation by macrophage interleukin 1. J Immunol 1983; 131: 2830-6.
72. Wiggins RC, Njoku, N, Sedor JR. Tissue factor production by cultured rat mesangial cells. Stimulation by TNF alpha and lipopolysaccharide. Kidney Int 1990; 37: 1281-5.
73. Kuo YC, Sun CM, Tsai WJ, Ou JC, Chen WP, Lin CY. Blocking of cell proliferation, cytokines production and genes expression following administration of chinese herbs in the human mesiangial cells. Life Sci 1999; 64: 2089-99.
74. Gupta M, Mazumder UK, Kumar RS, Sivakumar T, Gomathi P. Antioxidant and protective effects of Ervatamia coronaria stape., leaves against carbon tetrachloride-induced liver injury. Eur Bull Drug Res 2004; 12: 13-22.
75. Recknagael R. Carbon tetrachloride hepatoxicity. Pharmacol Rev 1967, 19: 145-96.
76. Taesotikul T, Panthong A, Kanjanapothi D, Verpoorte R, Scheffer JJ. Hippocratic screening of ethanolic extracts from two Tabernaemontana species. J Ethnopharmacol 1989; 27: 99-106.
77. Ingkaninan K, Temkitthawon P, Chuenchom K, Yuyaem T, Thongnoi W. Screening for acetylcholinesterase inhibitory activity in plants used in Thai traditional rejuvenating and neurotonic remedies. J Ethnopharmacol 2003; 89: 261-4.
78. Chattipakorn S, Pongpanparadorn A, Pratchayasakul W, Pongchaidacha A, Ingkaninan K, Chattipakorn N. Tabernaemontana divaricata extract inhibits neuronal acetylcholinesterase activity in rats. J Ethnopharmacol 2007; 110: 61-8.
79. Andrade MT, Lima JA, Pinto AC, Rezende CM, Carvalho MP, Epifanio RA. Indole alkaloids from Tabernaemontana australis (Muell. Arg) Miers that inhibit acetylcholinesterase enzyme. Bioorg Med Chem 2005; 13: 4092-5.
80. Farnsworth NR, Svoboda GN, Blomster RN. Antiviral activity of selected Catharanthus alkaloids. J Pharm Sci 1968; 57: 2174-5.
81. Rojas Hernandez NM, Diaz PC. Fungal activity of various alkaloids isolated from Catharanthus roseus G. Don. Rev Cubana Med Trop 1977; 29: 147-52.
82. Arens H, Borbe HO, Ulbrich B, Stockigt J. Detection of pericine, a new CNS-active indole alkaloid from Picralima nitida cell suspension culture by opiate receptor binding studies. Planta Med 1982; 46: 210-4.
83. Siems WG, Grune T, Beierl B, Zollner H, Esterbauer H. The metabolism of 4-hydroxynonenal, a lipid peroxidation product, is dependent on tumor age in Ehrlich mouse ascites cells. EXS 1992; 62: 124-35.
84. Fyfe MJ, Loftfield S, Goldman ID. A reduction in energy-dependent amino acid transport by microtubular inhibitors in Ehrlich ascites tumor cells. J Cell Physiol 1975; 86: 201-11.
85. Watanabe K, Williams EF, Law JS, West WL. Effects of vinca alkaloids on calcium-calmodulin regulated cyclic adenosine 3′,5′-monophosphatase phosphodiesterase activity from brain. Biochem Pharmacol 1981; 30: 335-40.
86. Ogata T, Li L, Yamada S, Yamamoto Y, Tanaka Y, Takei I, et al. Promotion of beta-cell differentiation by conophylline in fetal and neonatal rat pancreas. Diabetes 2004; 53: 2596-602.
87. Takatsuna H, Umezawa K. Screening of bioactive metabolites for pancreatic regeneration chemotherapy. Biomed Pharmacother 2004; 58: 610-3.
88. Kojima I, Umezawa K. Conophylline: a novel differentiation inducer for pancreatic beta cells. Int J Biochem Cell Biol 2006; 38: 923-30.
89. Atsumi S, Nagasawa A, Koyano T, Kowithayakornd T, Umezawa K. Suppression of TGF-beta signaling by conophylline via upregulation of c-Jun expression. Cell Mol Life Sci 2003; 60: 2516-25.
90. Gohda J, Inoue J, Umezawa K. Down-regulation of TNF-alpha receptors by conophylline in human T-cell leukemia cells. Int J Oncol 2003; 23: 1373-9.
91. Irie T, Kubushiro K, Suzuki K, Tsukazaki K, Umezawa K, Nozawa S. Inhibition of attachment and chemotactic invasion of uterine endometrial cancer cells by a new vinca alkaloid, conophylline. Anticancer Res 1999; 19: 3061-6.
92. Umezawa K, Taniguchi T, Toi M, Ohse T, Tsutsumi N, Yamamoto T, et al. Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude mice. Drugs Exp Clin Res 1996; 22: 35-40.
93. Kupchan SM, Bright A, Macko E. Tumor inhibitors. II. Alkaloids of Ervatamia dichotoma. Isolation, crystallization, and pharmacological properties of coronaridine. J Pharm Sci 1963; 52: 598-9.
94. Taesotikul T, Panthong A, Kanjanapothi D, Verpoorte R, Scheffer JJ. Anti-inflammatory, antipyretic and antinociceptive activities of Tabernaemontana pandacaqui Poir. J Ethnopharmacol 2003; 84: 31-5.
95. Taesotikul T, Panthong A, Kanjanapothi D, Verpoorte R, Scheffer JJ. Cardiovascular effects of Tabernaemontana pandacaqui. J Ethnopharmacol 1989; 27: 107-19.
96. Taesotikul T, Panthong A, Kanjanapothi D, Verpoorte R, Scheffer JJ. Cardiovascular activity of the crude alkaloidal fraction from Tabernaemontana pandacaqui in the rat. J Ethnopharmacol 1998; 59: 131-7.
97. Mehrotra PK, Kamboj VP. Hormonal profile of coronaridine hydrochloride-an antifertility agent of plant origin. Planta Med 1978; 33: 345-9.
98. Pace CJ, Glick SD, Maisonneuve IM. Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration. Eur J Pharmacol 2004; 492: 159-67.
99. Chen G, Bohner B. A study of central nervous system stimulants. J Pharmacol Exp Ther 1958; 123: 212-5.
100. Goutarel R, Gollnhofer O, Sillans R. Pharmacodynamics and therapeutic applications of iboga and ibogaine in psychotherapy and for controlling narcotic dependence. Psychedelic Monographs Essays 1993; 6: 70-111.
101. Lotsof HS, inventor; Rapid method for interrupting the narcotic addiction syndrome. United States patent US 4499096.1985.
102. Mash DC, Sanchez-Ramos J, Hearn WL, inventors; Noribogaine compounds for treating chemical dependency in mammals. (United States patent WO 9603127) 1996.
103. Aceto MD, Bowman ER, Harris LS, May EL. Dependence studies of new compounds in the rhesus monkey and mouse. NIDA Res Monogr 1991; 105: 640-81.
104. Cappendijk SL, Dzoljic MR. Inhibitory effects of ibogaine on cocaine self-administration in rats. Eur J Pharmacol 1993; 241: 261-5.
105. Glick SD, Rossman K, Rao NC, Maisonneuve IM, Carlson JN. Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor. Neuropharmacology 1992; 31: 497-500.
106. Glick SD, Rossman K, Steindorf S, Maisonneuve IM, Carlson JN. Effects of and after effects of ibogaine on morphine self-administration in rats. Eur J Pharmacol 1992; 195: 341-5.
107. Glick SD, Maisonneuve IS. Mechanisms of antiaddictive actions of ibogaine. Ann N Y Acad Sci 199-8; 844: 214-26.
108. Sershen H, Hashim A, Lajtha A. Ibogaine reduces preference for cocaine consumption in C57BL/6By mice. Pharmacol Biochem Behav 1994; 47: 13-9.
109. Sershen H, Hashim A, Lajtha A. Ibogaine and cocaine abuse: pharmacological interactions at dopamine and serotonin receptors. Brain Res Bull 1997; 42: 161-8.
110. Sheppard SG. A preliminary investigation of ibogaine: case reports and recommendations for further study. J Subst Abuse Treat 1994; 11: 379-85.
111. Alper KR. Ibogaine: a review. Alkaloids. Chem Biol 2001; 56: 1-38.
112. Zetler G, Lenschow E, Prenger-Berninghoff W. Action of 11 indole alkaloids on the guinea pig heart in vivo and in vitro, compared with those of 2 synthetic azepinoindoles, quinidine and quindonium. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 1968; 260: 26-49.
113. Raymond-Hamet AME. Is the true white ginseng of Korea endowed with the specific sympathicosthenic activity of most excitant drugs?. C R Hebd Seances Acad Sci 1962; 255: 3269-71.
114. Quevauvillera A, Foussard-Blanpin O, Coignard D. An alkaloid of Phyllanthus discoides (Euphorbiaceae) phyllalbine, a central and peripheral sympathomimetic. Therapie 1965; 20: 1033-41.
115. Okuyama E, Gao LH, Yamazaki M. Analgesic components from bornean medicinal plants, Tabernaemontana pauciflora Blume and Tabernaemontana pandacaqui Poir. Chem Pharm Bull (Tokyo) 1992; 40: 2075-9.
116. Zetler G, Singbartl G. Inhibition of cardiac effects of noradrenaline by eleven indole alkaloids, two azepinoindoles, quinidine, quindonium, and propranolol. Pharmacology 1970; 4: 129-42.
117. Zetler G. Some pharmacological properties of 12 natural and 11 partially synthetically derived indole alkaloids from tropical Apocyanaceae of the sub-tribe Tabernaemontana. Arzneimittelforschung 1964; 14: 1277-86.
118. Taesotikul T, Panthong A, Kanjanapothi D, Verpoorte R, Scheffer JJ. Neuropharmacological activities of the crude alkaloidal fraction from stems of Tabernaemontana pandacaqui Poir. J Ethaopharmacol 1998; 62: 229-34.
119. Melo AA, Querol CB, Henriques AT, Henriques JAP. Cytostatic, cytotoxic and mutagenic effects of voacristine, an indole alkaloid in wide-type and repair deficient yeast. Mutal Res 1986; 171: 17.